More on IPHA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Innate Pharma (NQ:IPHA)
Delayed: 1.88 -0.07 (3.59%)
Prev. Close $1.95  
Open$1.91 
52 Wk High$ 
52 Wk Low$ 
Day High$1.94 
Day Low$1.88 
P/E N/A  
EPS$ 
Volume8,468 

Friends, Peers and Foes (?): IPH SOBI (more...)

Sep 10, 2026 06:29 AM Form 6-K Innate Pharma SA For: Sep 10
Sep 10, 2026 01:00 AM Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
Aug 19, 2026 04:03 PM Form 6-K Innate Pharma SA For: Aug 19
Aug 14, 2026 06:13 AM Form 6-K Innate Pharma SA For: Aug 14
Aug 14, 2026 05:30 AM Innate Pharma Announces Conference Call and Webcast
Aug 11, 2026 04:02 PM Innate Pharma S.A. (IPHA) PT Raised to $9 at BTIG
Aug 11, 2026 06:51 AM Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright
Aug 11, 2026 06:11 AM Leerink Upgrades Innate Pharma S.A. (IPHA) to Outperform
Aug 10, 2026 06:06 AM Form 6-K Innate Pharma SA For: Aug 10
Aug 10, 2026 02:33 AM Sobi licenses lacutamab from Innate Pharma in $75M upfront deal
View All Articles

Entities mentioned with IPHA

View All Entities